Transformation of acetaminophen in solution containing both peroxymonosulfate and chlorine: Performance, mechanism, and disinfection by-product formation.

With the fast development of peroxymonosulfate (PMS)-dominating processes in drinking water and wastewater treatment, residual PMS is easy to come across chlorine as these processes are usually followed by secondary chlorine disinfection. The synergistic effect of PMS and chlorine on the degradation of micro-organic pollutants is investigated by selecting acetaminophen (ACT) as a reference compound for the first time in this study. Unlike conventional PMS or chlorine activation which generates reactive species such as hydroxyl radical (HO•), sulfate radical (SO4•-), chlorine radical (Cl•), and singlet oxygen (1O2), the efficient ACT removal is attributed to the direct catalytic chlorination by PMS due to the significantly enhanced consumption of chlorine along with negligible change of PMS concentration at neutral condition, and the same reaction pathways in both PMS/chlorine and chlorine processes. The kinetic study demonstrates that ACT oxidation by PMS/chlorine follows second order reaction, and the degradation efficiency can be promoted at alkaline conditions with peak rate constants at pH 9.0-10.0. The presence of chloride can enhance the removal of ACT, while ammonium and humic acid significantly retard ACT degradation. Higher formation of selected disinfection by-products (DBPs) is observed in the PMS/chlorine process than in the sole chlorination. This study highlights the important role of PMS in organic pollutants degradation and DBPs formation during the chlorination process.

The Spider Venom Peptide Lycosin-II Has Potent Antimicrobial Activity against Clinically Isolated Bacteria.

Antimicrobial peptides have been accepted as excellent candidates for developing novel antibiotics against drug-resistant bacteria. Recent studies indicate that spider venoms are the source for the identification of novel antimicrobial peptides. In the present study, we isolated and characterized an antibacterial peptide named lycosin-II from the venom of the spider Lycosa singoriensis. It contains 21 amino acid residue lacking cysteine residues and forms a typical linear amphipathic and cationic α-helical conformation. Lycosin-II displays potent bacteriostatic effect on the tested drug-resistant bacterial strains isolated from hospital patients, including multidrug-resistant A. baumannii, which has presented a huge challenge for the infection therapy. The inhibitory ability of lycosin-II might derive from its binding to cell membrane, because Mg(2+) could compete with the binding sites to reduce the bacteriostatic potency of lycosin-II. Our data suggest that lycosin-II might be a lead in the development of novel antibiotics for curing drug-resistant bacterial infections.